medi-5752,pembrolizumab,medi-5752
astrazeneca,merck
['medi5752 ', 'medi5752', 'pembro']
this looks good. medi5752 is a bi-specific anti pd1/ctla-4 antibody with handsome activity when compared with pembro/chemo, and more tolerable at the lower dose. #esmo22 bigger studies coming, can we have them please? #partnersincare 
Associate Professor and Medical Oncologist at University of Ottawa, Past President of Lung Cancer Canada, and a cricket fan!